Post-transplant changes in physical functioning and quality of life in patients undergoing two allogeneic hematopoietic stem cell transplants
- PMID: 40616729
- DOI: 10.1007/s12185-025-04030-z
Post-transplant changes in physical functioning and quality of life in patients undergoing two allogeneic hematopoietic stem cell transplants
Abstract
This study retrospectively examined changes in physical functioning and quality of life (QOL) in allogeneic hematopoietic stem cell transplantation (HSCT) recipients at their first (HSCT-1) and second (HSCT-2) transplantations. Seventeen patients who underwent HSCT-2 after relapse following HSCT-1 at our hospital between May 2013 and November 2023 and who underwent physical therapy evaluations before and after both transplantations were analyzed. Physical functioning was evaluated using handgrip strength as a measure of muscle strength, and exercise tolerance using the 6-min walk test (6MWT). QOL was assessed using the Medical Outcome Study 36-Item Short Form Health Survey (SF-36). Changes in physical functioning included handgrip strength (HSCT-1: - 9.3%; HSCT-2: - 18.3%; p < 0.05) and 6MWT findings (HSCT-1: - 5.1%; HSCT-2: - 12.6%; p < 0.05), which showed a significantly greater decline at HSCT-2. Physical functioning scores (SF-36) showed changes in QOL (HSCT-1: - 4.3 points; HSCT-2: - 23.4 points; p < 0.05), with a significantly greater reduction at HSCT-2. The findings indicate that the decline in physical functioning and QOL was more pronounced during the second transplantation than during the first. This highlights the importance of prioritizing strategies to maintain physical activity levels, particularly during the second transplantation process.
Keywords: Exercise therapy; Physical functioning change; Quality of life; Second allogeneic hematopoietic stem cell transplantation.
© 2025. The Author(s), under exclusive licence to Japanese Society of Hematology.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest.
Similar articles
-
Mortality Is Increased in Those with a ≥10% Reduction in Spirometry Following Allogeneic Hematopoietic Stem Cell Transplant: A Retrospective 5-Year Follow-up Study from a Single Transplant Service.Transplant Cell Ther. 2025 Jul;31(7):448.e1-448.e9. doi: 10.1016/j.jtct.2025.03.019. Epub 2025 Apr 3. Transplant Cell Ther. 2025. PMID: 40187496
-
Exercise interventions for adults after liver transplantation.Cochrane Database Syst Rev. 2023 May 19;5(5):CD013204. doi: 10.1002/14651858.CD013204.pub2. Cochrane Database Syst Rev. 2023. PMID: 37204002 Free PMC article.
-
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee.Cytotherapy. 2025 Apr;27(4):438-445. doi: 10.1016/j.jcyt.2024.11.016. Epub 2024 Dec 2. Cytotherapy. 2025. PMID: 39708044
-
Stem cell transplantation for systemic sclerosis.Cochrane Database Syst Rev. 2022 Jul 29;7(7):CD011819. doi: 10.1002/14651858.CD011819.pub2. Cochrane Database Syst Rev. 2022. PMID: 35904231 Free PMC article.
-
Exercise interventions on health-related quality of life for people with cancer during active treatment.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895974 Free PMC article.
References
-
- Lu Y, Zhang JP, Zhao YL, Xiong M, Sun RJ, Cao XY, et al. Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study. Front Immunol. 2023;13:1066748. - DOI - PubMed - PMC
LinkOut - more resources
Full Text Sources